News by: Himanshu Singh
And Barclays close to naming American investment banker Jes Staley as its new chief executive.
The Dow advanced for a seventh straight session, led by gains in UnitedHealth Group, which rose 2.7%.
Late gains in Wall Street on Friday and a rebound in the commodities complex prompted some investors to hunt for bargains.
And commodity contagion has sparked a second credit crisis just like 2007 as investors panic.
And a group of four American pension and investment funds have launched a multi-million dollar legal action against Tesco over its ‘massive restatement’ of profits.
And Apple has pulled adblocker that worked on mobile apps such as Facebook, citing concerns about customer security.
And Volkswagen’s emissions-rigging scandal is “on the same scale as Enron”, say US lawmakers.
Energy shares rallied after US-traded crude futures gained 3.4% to $49.43 a barrel, and briefly surmounted $50 a barrel in intraday trading.
And IMF has warned of looming $3 trillion corporate credit crunch as debtors face day of reckoning.
A rebound in biotechnology companies propelled the S&P 500 to its highest level in three weeks.
And Britain shines even as the world sees the slowest period of growth since the depths of the financial crisis, according to the IMF.
A surge in DuPont helped keep the Dow Jones in positive territory but the S&P 500 and Nasdaq lost ground, with a sharp drop in biotech stocks.
And the US, Japan and 10 countries struck Trans-Pacific Partnership deal covering 40% of the global economy.
Industrials, energy, telecommunications and materials stocks posted strong rally on Monday.
And AstraZeneca avoids paying UK corporation tax over two years despite global profits of £3 billion.
A weaker-than-expected US jobs report reduced the case for the Fed to raise interest rates.
And Glencore would listen to offers for a takeover of the entire company but its management does not believe there are any buyers.
And disappointing growth in the US jobs market prompts markets to give up hope of a Fed rate rise this year.
And shares in Paul Taubman’s boutique PJT Partners sink on debut.
Stocks remained in negative territory for most of the session amid uncertainty about the strength of Friday’s employment report.